2m 2m 2m 2m 2m 2m 2m
TYRA BIOSCIS (TYRA)
NASDAQ
$30.04-$0.02 (-0.08%)
Price as of Jun 23, 2026 5:39 PM EDT- $1.8BMarket Cap
- 210.40%1-Year Change
- BiotechnologyIndustry
TYRA BIOSCIS (TYRA)
$30.04-$0.02 (-0.08%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -102.9M +28.54% | -80.1M +28.09% | -62.5M +45.36% | -43.0M +108.41% | |
Depreciation and Amortization Expense | 546,000 +5.20% | 519,000 +47.03% | 353,000 +19.26% | 296,000 +111.43% | |
Total Operating Expenses | 132.8M +27.44% | 104.2M +30.31% | 79.9M +35.67% | 58.9M +124.16% | |
Operating Profit | -132.8M +27.44% | -104.2M +30.31% | -79.9M +35.67% | -58.9M +124.16% | |
Interest Income | 12.8M -27.58% | 17.7M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 12.8M -27.58% | 17.7M N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 12.8M -27.58% | 17.7M +63.69% | 10.8M +200.14% | 3.6M +60,133.33% | |
Income before Taxes | -132.8M +27.44% | -104.2M +30.31% | -79.9M +35.67% | -58.9M +124.16% | |
Income Taxes | 0 N/A | 0 N/A | 0 -100.00% | 2,000 +100.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -119.9M +38.70% | -86.5M +25.09% | -69.1M +24.96% | -55.3M +110.41% | |
Net Income from Continuing Operations Applicable to Common | -119.9M +38.70% | -86.5M +25.09% | -69.1M +24.96% | -55.3M +110.41% | |
Basic EPS and Net Income | -2.01 +33.11% | -1.51 -6.79% | -1.62 +22.73% | -1.32 -30.89% | |
Diluted EPS and Net Income | -2.01 +33.11% | -1.51 -6.79% | -1.62 +22.73% | -1.32 -30.89% | |
Basic Weighted Average Shares | 59.6M +4.17% | 57.2M +33.98% | 42.7M +1.96% | 41.9M +203.94% | |
Diluted Weighted Average Shares | 59.6M +4.17% | 57.2M +33.98% | 42.7M +1.96% | 41.9M +203.94% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 77.4M -15.85% | 92.0M +58.55% | 58.0M -76.91% | 251.2M -16.87% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 77.4M -15.85% | 92.0M +58.55% | 58.0M -76.91% | 251.2M -16.87% | |
Total Current Assets | 265.4M -23.60% | 347.5M +64.15% | 211.7M -17.73% | 257.3M -15.38% | |
Accumulated Depreciation | N/A N/A | 1.3M +58.74% | 807,000 +75.05% | 461,000 +172.78% | |
Property and Plant and Equipment and Net | 1.3M -20.41% | 1.7M +1.41% | 1.6M +51.16% | 1.1M +4.87% | |
Total Long-Term Assets | 9.3M +25.70% | 7.4M +46.58% | 5.0M +15.68% | 4.3M +1,294.23% | |
Total Assets | 282.6M -22.27% | 363.6M +60.97% | 225.9M -15.15% | 266.2M -13.21% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.0M 0.00% | 1.0M 0.00% | 1.0M +400.00% | 200,000 0.00% | |
Total Current Liabilities | 18.1M +23.98% | 14.6M -4.82% | 15.3M +168.95% | 5.7M +57.66% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 0 -100.00% | 3,000 -93.48% | 46,000 -72.78% | 169,000 -53.95% | |
Total Liabilities | 23.4M +14.82% | 20.4M -5.50% | 21.6M +158.56% | 8.4M +68.25% | |
Retained Earnings | -371.3M +47.73% | -251.3M +52.47% | -164.8M +72.24% | -95.7M +137.04% | |
Total Stockholders Equity | 259.2M -24.47% | 343.2M +68.00% | 204.3M -20.78% | 257.8M -14.55% | |
Total Shares Outstanding | 53.7M +5.83% | 50.7M +17.96% | 43.0M +1.58% | 42.4M +2.20% | |
Cash Flow | |||||
Cash from Operating Activities | -95.1M +36.36% | -69.8M +39.16% | -50.1M -0.29% | -50.3M +111.77% | |
Capital Expenditures | 141,000 -78.77% | 664,000 -13.77% | 770,000 +37.75% | 559,000 -15.43% | |
Cash from Investing Activities | 72.5M +173.64% | -98.4M -31.95% | -144.6M +25,768.52% | -559,000 -13.33% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.1M -95.99% | 202.1M +13,051.40% | 1.5M +143.20% | 632,000 -99.80% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -37.13% +26.52% | -29.34% +4.43% | -28.10% +45.49% | -19.31% N/A | |
Return on Equity | -39.83% +26.05% | -31.60% +5.59% | -29.92% +51.32% | -19.77% N/A | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 14.67 -38.38% | 23.81 +72.46% | 13.80 -69.41% | 45.13 N/A | |
Cash Ratio | 4.28 -32.13% | 6.30 +66.57% | 3.78 -91.41% | 44.06 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow